PDCD1 and esophageal squamous cell carcinoma: Extensive randomized controlled trials like Keynote-590 and Checkmate 648 have shown that combining PD-1 inhibitors with chemotherapy is more effective than solely chemotherapy as an initial treatment for advanced ESCC (16, 17).